Home › Leucemia acuta bifenotipica › California
Studi clinici su Leucemia acuta bifenotipica nello stato di California
15 studi su Leucemia acuta bifenotipica cercano partecipanti presso sedi nello stato di California.
Città nello stato di California
- Baldwin Park6 studi
- Los Angeles6 studi
- San Diego5 studi
- San Francisco5 studi
- Mountain View4 studi
- Orange4 studi
- Sacramento3 studi
- Long Beach3 studi
- Oakland3 studi
- San Bernardino3 studi
Testo ufficiale dello studio (inglese)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- City of Hope, Duarte
- UC Davis, Sacramento
- Stanford Health Care, Stanford
In reclutamentoFase 1
Età da 12 a 78 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT03802695Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- UCSF Benioff Children's Hospital Oakland, Oakland
- e altri 4
In reclutamentoFase 2
365 Days · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06317662Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Kaiser Permanente Downey Medical Center, Downey
- City of Hope Comprehensive Cancer Center, Duarte
- Loma Linda University Medical Center, Loma Linda
- e altri 14
In reclutamentoFase 3
365 Days – 25 Years · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Kaiser Permanente Downey Medical Center, Downey
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- e altri 8
In reclutamentoFase 1/2
Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Rady Children's Hospital, San Diego
In reclutamentoFase 2
Età da 1 a 18 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT06390319Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- City of Hope, Duarte
- Valkyrie Clinical Trials, Los Angeles
In reclutamentoFase 1/2
Età da 13 a 90 · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT06533579Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Rady Children's Hospital, San Diego
In reclutamentoFase 1
Età da 1 a 30 · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT06177067Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- Rady Children's Hospital, San Diego
In reclutamentoFase 4
Età da 1 a 18 · Tutti i sessi · Aggiornato il 14 lug 2026 · NCT06289673Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 lug 2026 · NCT07216443Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Stanford University, Palo Alto
In reclutamentoFase 1
Età da 18 a 70 · Tutti i sessi · Aggiornato il 23 giu 2026 · NCT06551584A Study of Revumenib and Mezigdomide in People With Leukemia
- City of Hope Cancer Center (Data collection only), Duarte
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT07356154The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- City of Hope, Duarte
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
- e altri 1
In reclutamentoFase 1/2
Età da 12 a 95 · Tutti i sessi · Aggiornato il 15 apr 2026 · NCT04329728Venetoclax Basket Trial for High Risk Hematologic Malignancies
- University of California San Francisco-Benioff Children's Hospital, San Francisco
In reclutamentoFase 1
Età da 1 a 40 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT05292664Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
- City of Hope Medical Center, Duarte
In reclutamentoFase 1
Età 2 e oltre · Tutti i sessi · Aggiornato il 5 mar 2026 · NCT06575296Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital Orange County, Orange
- UCSF School of Medicine, San Francisco
In reclutamentoFase 1
Età da 1 a 21 · Tutti i sessi · Aggiornato il 6 dic 2024 · NCT05476770Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.